ProPhase Labs, Inc. (PRPH) stock
PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-6.16%)
Close on Oct 19, 2026Market cap $119.68KP/E –Yield –
ProPhase Labs total assets
Total assets on the balance sheet at the end of each period.
ProPhase Labs's total assets was $57.41M at Jun 30, 2026. For fiscal 2025 it was $59.87M, down 5.3% from the year before. Over ten years it grew 15.0% a year on average. The highest annual figure on record is $91.93M in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $59.87M | -5.3% |
| FY2024 | Dec 31, 2024 | $63.20M | -31.2% |
| FY2023 | Dec 31, 2023 | $91.93M | +4.9% |
| FY2022 | Dec 31, 2022 | $87.65M | -1.8% |
| FY2021 | Dec 31, 2021 | $89.30M | +184.3% |
| FY2020 | Dec 31, 2020 | $31.41M | +155.9% |
| FY2019 | Dec 31, 2019 | $12.27M | -40.8% |
| FY2018 | Dec 31, 2018 | $20.74M | -38.4% |
| FY2017 | Dec 31, 2017 | $33.66M | +162.9% |
| FY2016 | Dec 31, 2016 | $12.80M | -13.7% |
| FY2015 | Dec 31, 2015 | $14.83M | -7.6% |
| FY2014 | Dec 31, 2014 | $16.06M | -7.8% |
| FY2013 | Dec 31, 2013 | $17.42M | +4.6% |
| FY2012 | Dec 31, 2012 | $16.66M | -12.7% |
| FY2011 | Dec 31, 2011 | $19.08M | -12.1% |
| FY2010 | Dec 31, 2010 | $21.70M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $57.41M | +36.6% |
| Q1 FY2026 | Mar 31, 2026 | $58.47M | +16.7% |
| Q4 FY2025 | Dec 31, 2025 | $59.87M | -5.3% |
| Q3 FY2025 | Sep 30, 2025 | $65.70M | -28.4% |
| Q2 FY2025 | Jun 30, 2025 | $42.04M | -55.1% |
| Q1 FY2025 | Mar 31, 2025 | $50.11M | -44.3% |
| Q4 FY2024 | Dec 31, 2024 | $63.20M | -31.2% |
| Q3 FY2024 | Sep 30, 2024 | $91.81M | +0.1% |
| Q2 FY2024 | Jun 30, 2024 | $93.68M | +2.9% |
| Q1 FY2024 | Mar 31, 2024 | $90.03M | -5.6% |
| Q4 FY2023 | Dec 31, 2023 | $91.93M | +4.9% |
| Q3 FY2023 | Sep 30, 2023 | $91.71M | -6.3% |
| Q2 FY2023 | Jun 30, 2023 | $91.06M | -7.0% |
| Q1 FY2023 | Mar 31, 2023 | $95.37M | -4.3% |
| Q4 FY2022 | Dec 31, 2022 | $87.65M | -1.8% |
| Q3 FY2022 | Sep 30, 2022 | $97.88M | +34.8% |
| Q2 FY2022 | Jun 30, 2022 | $97.95M | +28.3% |
| Q1 FY2022 | Mar 31, 2022 | $99.67M | +16.6% |
| Q4 FY2021 | Dec 31, 2021 | $89.30M | +184.3% |
| Q3 FY2021 | Sep 30, 2021 | $72.63M | +215.3% |
| Q2 FY2021 | Jun 30, 2021 | $76.32M | +516.8% |
| Q1 FY2021 | Mar 31, 2021 | $85.44M | +620.0% |
| Q4 FY2020 | Dec 31, 2020 | $31.41M | +155.9% |
| Q3 FY2020 | Sep 30, 2020 | $23.03M | +47.6% |
| Q2 FY2020 | Jun 30, 2020 | $12.38M | -21.7% |
| Q1 FY2020 | Mar 31, 2020 | $11.87M | -28.4% |
| Q4 FY2019 | Dec 31, 2019 | $12.27M | -40.8% |
| Q3 FY2019 | Sep 30, 2019 | $15.60M | -24.2% |
| Q2 FY2019 | Jun 30, 2019 | $15.80M | -28.6% |
| Q1 FY2019 | Mar 31, 2019 | $16.57M | -50.9% |
| Q4 FY2018 | Dec 31, 2018 | $20.74M | -38.4% |
| Q3 FY2018 | Sep 30, 2018 | $20.58M | -47.4% |
| Q2 FY2018 | Jun 30, 2018 | $22.12M | -55.8% |
| Q1 FY2018 | Mar 31, 2018 | $33.72M | -41.4% |
| Q4 FY2017 | Dec 31, 2017 | $33.66M | +162.9% |
| Q3 FY2017 | Sep 30, 2017 | $39.08M | +205.6% |
| Q2 FY2017 | Jun 30, 2017 | $50.10M | – |
| Q1 FY2017 | Mar 31, 2017 | $57.54M | – |
| Q4 FY2016 | Dec 31, 2016 | $12.80M | – |
| Q3 FY2016 | Sep 30, 2016 | $12.79M | – |
See a number that looks wrong?